Adlai Nortye (NASDAQ:ANL) Shares Up 1% – Time to Buy?

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL)’s stock price traded up 1% on Wednesday . The company traded as high as $1.55 and last traded at $1.5350. 11,895 shares were traded during trading, a decline of 63% from the average session volume of 31,907 shares. The stock had previously closed at $1.52.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Adlai Nortye in a report on Wednesday, October 8th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce”.

Adlai Nortye Trading Up 1.0%

The firm’s fifty day moving average price is $1.46 and its 200-day moving average price is $1.57.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.